Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 6
1997 4
1998 4
1999 2
2000 3
2001 3
2002 6
2003 4
2004 5
2005 3
2006 5
2007 3
2008 9
2009 5
2010 3
2011 1
2012 5
2013 10
2014 2
2015 3
2016 3
2017 4
2018 6
2019 2
2020 2
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

106 results
Results by year
Filters applied: . Clear all
Page 1
Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.
Lee SH, Hu W, Matulay JT, Silva MV, Owczarek TB, Kim K, Chua CW, Barlow LJ, Kandoth C, Williams AB, Bergren SK, Pietzak EJ, Anderson CB, Benson MC, Coleman JA, Taylor BS, Abate-Shen C, McKiernan JM, Al-Ahmadie H, Solit DB, Shen MM. Lee SH, et al. Among authors: abate shen c. Cell. 2018 Apr 5;173(2):515-528.e17. doi: 10.1016/j.cell.2018.03.017. Cell. 2018. PMID: 29625057 Free PMC article.
Modelling bladder cancer in mice: opportunities and challenges.
Kobayashi T, Owczarek TB, McKiernan JM, Abate-Shen C. Kobayashi T, et al. Among authors: abate shen c. Nat Rev Cancer. 2015 Jan;15(1):42-54. doi: 10.1038/nrc3858. Nat Rev Cancer. 2015. PMID: 25533675 Free PMC article. Review.
ARID1A promotes genomic stability through protecting telomere cohesion.
Zhao B, Lin J, Rong L, Wu S, Deng Z, Fatkhutdinov N, Zundell J, Fukumoto T, Liu Q, Kossenkov A, Jean S, Cadungog MG, Borowsky ME, Drapkin R, Lieberman PM, Abate-Shen CT, Zhang R. Zhao B, et al. Among authors: abate shen ct. Nat Commun. 2019 Sep 6;10(1):4067. doi: 10.1038/s41467-019-12037-4. Nat Commun. 2019. PMID: 31492885 Free PMC article.
NSD2 is a conserved driver of metastatic prostate cancer progression.
Aytes A, Giacobbe A, Mitrofanova A, Ruggero K, Cyrta J, Arriaga J, Palomero L, Farran-Matas S, Rubin MA, Shen MM, Califano A, Abate-Shen C. Aytes A, et al. Among authors: abate shen c. Nat Commun. 2018 Dec 5;9(1):5201. doi: 10.1038/s41467-018-07511-4. Nat Commun. 2018. PMID: 30518758 Free PMC article.
A modular master regulator landscape controls cancer transcriptional identity.
Paull EO, Aytes A, Jones SJ, Subramaniam PS, Giorgi FM, Douglass EF, Tagore S, Chu B, Vasciaveo A, Zheng S, Verhaak R, Abate-Shen C, Alvarez MJ, Califano A. Paull EO, et al. Among authors: abate shen c. Cell. 2021 Jan 21;184(2):334-351.e20. doi: 10.1016/j.cell.2020.11.045. Epub 2021 Jan 11. Cell. 2021. PMID: 33434495
Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer Metastasis.
Leibold J, Ruscetti M, Cao Z, Ho YJ, Baslan T, Zou M, Abida W, Feucht J, Han T, Barriga FM, Tsanov KM, Zamechek L, Kulick A, Amor C, Tian S, Rybczyk K, Salgado NR, Sánchez-Rivera FJ, Watson PA, de Stanchina E, Wilkinson JE, Dow LE, Abate-Shen C, Sawyers CL, Lowe SW. Leibold J, et al. Among authors: abate shen c. Cancer Discov. 2020 Jul;10(7):1038-1057. doi: 10.1158/2159-8290.CD-19-1242. Epub 2020 May 6. Cancer Discov. 2020. PMID: 32376773 Free PMC article.
A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guérin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the Bladder.
DeCastro GJ, Sui W, Pak JS, Lee SM, Holder D, Kates MM, Virk RK, Drake CG, Anderson CB, James B, Abate-Shen CT, McKiernan JM. DeCastro GJ, et al. Among authors: abate shen ct. J Urol. 2020 Aug;204(2):247-253. doi: 10.1097/JU.0000000000000919. Epub 2020 Mar 2. J Urol. 2020. PMID: 32118506 Clinical Trial.
106 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page